MarketWatch: Health Round-up
Pages: 52
Publisher: Datamonitor
Date Published: September 2006
Format: PDF
Price: $200
Overview
Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.
Table of Contents
In this month’s MarketWatch…
Pharmaceutical Company Round-up
Page 3
Cancer Update
Page 4 – News Round-up
Page 7 – Opinion: Novartis: Tasigna filing brought forward…
Page 7 – Opinion: Roche: Xelox to challenge FOLFOX in colorectal cancer…
Page 8 – Opinion: Novelos Therapeutics: fast track presents new opportunities…
Cardiovascular Update
Page 10 – News Round-up
Page 13 – Opinion: Pfizer: a strategic reversal of fortunes?
Page 13 – Opinion: Sanofi-Aventis/Bristol-Myers Squibb: Plavix threat looms nearer…
Page 14 – Opinion: Atrial fibrillation: guidelines put stroke in focus…
Page 15 – Opinion: Apotex: generic launch accelerates threat to Plavix…
CNS Update
Page 16 – News Round-up
Page 19 – Opinion: Elan/Biogen Idec: Tysabri back on the shelves…
Page 20 – Opinion: UCLA: epilepsy ‘brain pacemaker’ won’t outpace drugs…
Page 21 – Opinion: Cephalon: Sparlon rejection could prove a blessing in disguise…
IDI Update
Page 22 – News Round-up
Page 25 – Opinion: Critical Therapeutics: more user-friendly zileuton on the way…
Page 26 – Opinion: Roche/Ipsen: the anti-diabetics race is on…
Page 26 – Opinion: UCB: Cimzia making good progress…
Page 28 – Feature Analysis: AstraZeneca’s Symbicort the first of many new combination drugs to come…
Infectious Diseases Update
Page 30 – News Round-up
Page 32 – Opinion: Crucell: failed vaccine disappoints…
Page 33 – Opinion: Transition Therapeutics: showing potential in hepatitis…
Company Spotlight
Page 34 – Novartis AG
Biotechnology Update
Page 40 – Biotech News Round-up
Page 43 – Feature Analysis: Directed molecular evolution: lifecycle management for biologics…
Company Spotlight
Page 45 – Genzyme Corporation
Index
Page 51 – Pharma companies
Page 51 – Biotech companies
Page 52 – Key drugs
